GlassScriptPhysician profile
Joshua L Hare
NPI 1811121924
$4,901.13
in general payments reported to CMS, 2019-2025
41 companies · $883 in 2025
The $883 reported for 2025 was more than what 94% of Addiction Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $115).
See the full distribution for Addiction Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $350 · 2021: $441 · 2022: $415 · 2023: $801 · 2024: $1,323 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,007.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,006.84 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $746.13 | 2019-2025 | Relistor |
| Spinefrontier, INC. | $649.26 | 2024-2025 | Inspan, Facetfuse, Nanofuse |
| Boston Scientific Corporation | $540.23 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbott Laboratories | $357.29 | 2020-2024 | Eterna, Proclaim |
| Painteq LLC | $142.15 | 2021-2024 | Painteq |
| Indivior INC. | $141.32 | 2019-2020 | |
| Nalu Medical, INC. | $127.17 | 2022-2024 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $117.22 | 2019 | |
| Collegium Pharmaceutical, INC. | $91.68 | 2022-2025 | Belbuca, Xtampza |
| Curonix LLC | $70.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $69.36 | 2019-2025 | |
| Saluda Medical Americas, INC. | $60.21 | 2024-2025 | Evoke |
| Pacira Therapeutics, INC. | $56.81 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $56.32 | 2021 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $54.97 | 2021-2024 | Mild Device Kit |
| Pfizer INC. | $53.68 | 2019 | |
| Stimwave Technologies Incorporated | $50.34 | 2022 | |
| Nevro Corp. | $49.63 | 2023-2024 | Senza |
| Horizon Therapeutics Plc | $43.93 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $34.24 | 2019 | |
| Scilex Pharmaceuticals INC. | $33.85 | 2022-2023 | Ztlido |
| Forte Bio-Pharma LLC | $33.41 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Novartis Pharmaceuticals Corporation | $29.12 | 2019-2020 | |
| Amgen INC. | $26.83 | 2020-2024 | Evenity, Prolia |
| Stryker Corporation | $23.36 | 2024 | Mild Device Kit |
| Masimo Corporation | $20.84 | 2023 | Patient Safetynet System |
| Valinor Pharma, LLC | $19.81 | 2025 | Movantik |
| Olympus America INC. | $19.05 | 2019 | |
| Biotronik Nro, INC. | $18.43 | 2025 | Prospera |
| Globus Medical, INC. | $17.96 | 2025 | Vyrsa V1 |
| Grt US Holding, INC. | $17.81 | 2022 | |
| Daiichi Sankyo INC. | $16.26 | 2019 | |
| Redhill Biopharma INC. | $16.12 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.53 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.68 | 2022 | |
| Allergan, INC. | $13.56 | 2019 | |
| Vertiflex, INC. | $12.57 | 2019 | |
| Ethicon US, LLC | $11.87 | 2020 | |
| Merit Medical Systems INC | $11.19 | 2021 | |
| Kaleo, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Hare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.